{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T06:46:15Z","timestamp":1649054775067},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12325-008-0030-1","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T05:51:51Z","timestamp":1205473911000},"page":"274-279","source":"Crossref","is-referenced-by-count":5,"title":["A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: Are they an appropriate tool for drug screening?"],"prefix":"10.1007","volume":"25","author":[{"given":"Didem","family":"Dayanga\u00e7-Erden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haluk","family":"Topalo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayat","family":"Erdem-Yurter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,14]]},"reference":[{"key":"30_CR1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","volume":"1","author":"J. Pearn","year":"1980","unstructured":"Pearn J. Classification of spinal muscular atrophies. Lancet. 1980;1:919\u2013922.","journal-title":"Lancet"},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"T.O. Crawford","year":"1996","unstructured":"Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis. 1996;3:97\u2013110.","journal-title":"Neurobiol Dis"},{"key":"30_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S. Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, et al. Identification and characterization of the spinal muscular atrophy determining gene. Cell. 1995;80:155\u2013165.","journal-title":"Cell"},{"key":"30_CR4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0387-7604(98)00063-1","volume":"21","author":"H. Erdem","year":"1999","unstructured":"Erdem H, Pehlivan S, Topalo\u011flu H, et al. Deletion analysis in Turkish patients with spinal muscular atrophy. Brain Dev. 1999;21:86\u201389.","journal-title":"Brain Dev"},{"key":"30_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/4.4.631","volume":"4","author":"N.R. Rodrigues","year":"1995","unstructured":"Rodrigues NR, Owen N, Talbot K, et al. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 1995;4:631\u2013634.","journal-title":"Hum Mol Genet"},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/513913","volume":"61","author":"A.H. Burghes","year":"1997","unstructured":"Burghes AH. When is a deletion not a deletion? When it is converted. Am J Hum Genet. 1997;61:9\u201315.","journal-title":"Am J Hum Genet"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"C.L. Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A. 1999;96:6307\u20136311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"J.G. Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, et al. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A. 2001;98:9808\u20139813.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR9","first-page":"1","volume":"12","author":"C. Andreassi","year":"2003","unstructured":"Andreassi C, Angelozzi C, Tiziano FD, et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet. 2003;12:1\u20137.","journal-title":"Eur J Hum Genet"},{"key":"30_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"C.J. Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA, et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol. 2003;54:647\u2013654.","journal-title":"Ann Neurol"},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L. Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E, et al. Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet. 2003;12:2481\u20132489.","journal-title":"Hum Mol Genet"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","volume":"98","author":"E. Hahnen","year":"2006","unstructured":"Hahnen E, Eyupoglu IY, Brichta L, et al. In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem. 2006;98:193\u2013202.","journal-title":"J Neurochem"},{"key":"30_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","volume":"120","author":"M. Riessland","year":"2006","unstructured":"Riessland M, Brichta L, Hahnen E, et al. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells. Hum Genet. 2006;120:101\u2013110.","journal-title":"Hum Genet"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V84.1.339.339","volume":"84","author":"G.J. Dover","year":"1994","unstructured":"Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 1994;84:339\u2013343.","journal-title":"Blood"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11940-003-0037-5","volume":"5","author":"S. Kleppe","year":"2003","unstructured":"Kleppe S, Mian A, Lee B. Urea cycle disorders. Curr Treat Options Neurol. 2003;5:309\u2013319.","journal-title":"Curr Treat Options Neurol"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00279094","volume":"73","author":"H. Neitzel","year":"1986","unstructured":"Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 1986;73:320\u2013326.","journal-title":"Hum Genet"},{"key":"30_CR17","volume-title":"User Bulletin 2: ABI Prism 7700 Sequence Detection System, relative quantitation of gene expression","author":"Applied Biosystems.","year":"1997","unstructured":"Applied Biosystems. User Bulletin 2: ABI Prism 7700 Sequence Detection System, relative quantitation of gene expression. Foster City, CA: Applied Biosystems; 1997."},{"key":"30_CR18","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1128\/JVI.77.8.5008-5013.2003","volume":"77","author":"S. Barth","year":"2003","unstructured":"Barth S, Liss M, Voss MD, et al. Epstein Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein. J Virol. 2003;77:5008\u20135013.","journal-title":"J Virol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0030-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0030-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T03:32:19Z","timestamp":1588476739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0030-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0030-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}